openPR Logo
Press release

North America Diverticular Treatment Market to Surpass US$ 1.9 Bn by 2031 Amid Rising Prevalence & Advancements in Treatment - TMR Study

03-24-2025 06:11 AM CET | Health & Medicine

Press release from: Transparency Market Research

North America Diverticular Treatment

North America Diverticular Treatment

The North America Diverticular Treatment Market was valued at US$ 986.6 Mn in 2022 and is projected to expand at a CAGR of 7.6% from 2023 to 2031, surpassing US$ 1.9 Bn by the end of 2031. Increasing healthcare awareness, advancements in drug formulations, and improvements in diagnostic technologies are fueling market growth.

Diverticular disease, a condition characterized by the formation of small pouches (diverticula) in the walls of the colon, is increasingly prevalent in North America. Lifestyle changes, dietary habits, and an aging population are key factors contributing to the rising incidence of diverticulitis and related complications. The demand for effective treatment options, including medications, dietary modifications, and surgical interventions, is driving market growth in the region.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85622

Analyst Viewpoint

The North America Diverticular Treatment Market is expected to witness significant growth due to increasing disease prevalence, advancements in drug therapies, and improved healthcare infrastructure. The shift towards personalized medicine and non-surgical treatment approaches will further shape market dynamics. Companies investing in innovative treatment options and expanding their presence in outpatient care settings will gain a competitive advantage.

Key Market Drivers

Increasing Prevalence of Diverticular Disease: Rising cases of diverticulosis and diverticulitis among the aging population are boosting the demand for advanced treatment options.

Advancements in Drug Development: Pharmaceutical companies are investing in research to develop more effective antibiotics, anti-inflammatory drugs, and biologics for managing diverticular disease.

Growing Awareness and Preventive Healthcare: Public health initiatives emphasizing dietary changes, probiotics, and fiber intake are contributing to early disease management and reducing severe complications.

Improved Diagnostic Techniques: Enhanced imaging techniques, such as high-resolution colonoscopies and CT scans, allow for early detection and better treatment planning.

Expanding Healthcare Infrastructure: Increasing investments in healthcare facilities, particularly in the U.S. and Canada, are supporting market expansion.

Competitive Landscape
Key players operating in the North America Diverticular Treatment Market include:

Pfizer, Inc.
Novartis AG
Bayer AG
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Johnson & Johnson
Mallinckrodt Pharmaceuticals
Abbott Laboratories
GSK plc

Recent Developments
2023: Pfizer Inc. launched a new antibiotic formulation for diverticulitis treatment, improving efficacy and reducing side effects.

2022: Johnson & Johnson introduced a minimally invasive surgical technique for diverticular disease, reducing hospital stay durations.

2021: AbbVie Inc. invested in clinical trials for an anti-inflammatory drug targeting recurrent diverticulitis.

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85622

Market Trends and Opportunities

Rise in Non-Surgical Treatment Approaches
There is a growing preference for non-invasive treatment options such as dietary modifications, probiotics, and pharmacological interventions over traditional surgical procedures.

Adoption of Minimally Invasive Surgical Techniques
When surgical intervention is necessary, minimally invasive techniques like laparoscopic surgery are becoming the preferred choice due to shorter recovery times and lower post-operative complications.

Advancements in Personalized Medicine
The integration of personalized treatment approaches, including genetic profiling and microbiome analysis, is improving patient outcomes by offering targeted therapies.

Market Segmentation

Type

Diverticulosis
Diverticulitis
Diverticular Hemorrhage

Treatment

Medication
Pain Reliever
Antibiotics
Amebicides
Sulfonamides
Quinolones and Fluoroquinolones
Lincomycin Derivatives
Miscellaneous Antibiotics
Anticholinergics / Antispasmodics
Nutritional Supplements
Probiotics

Route of Administration

Oral
Parenteral

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:
United States - Dominates the market with advanced healthcare infrastructure and increasing awareness.

Canada - Growing demand due to an aging population and expanding healthcare facilities.

Future Outlook
The market will continue evolving with the adoption of advanced diagnostics, targeted drug therapies, and improved surgical techniques. Strengthening preventive healthcare strategies and increasing awareness about dietary modifications will play a crucial role in managing the disease burden effectively. Market players focusing on R&D and strategic partnerships will likely experience sustained growth in the coming years.

Explore Latest Research Reports by Transparency Market Research:

Dental Gypsum Market- https://www.globenewswire.com/news-release/2024/03/14/2846441/32656/en/Dental-Gypsum-Market-Projected-to-Reach-USD-180-1-million-by-2031-Growing-at-a-CAGR-of-5-1-Transparency-Market-Research-Inc.html

Bio-based Bisphenol-A Market- https://www.globenewswire.com/en/news-release/2022/10/10/2531007/0/en/Bio-based-Bisphenol-A-Market-to-reach-US-262-1-Mn-by-2031-TMR-Study.html

Bio-Emulsion Polymers Market- https://www.prnewswire.com/news-releases/bio-emulsion-polymers-market-to-reach-us-2-bn-by-2030-tmr-study-301644416.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Diverticular Treatment Market to Surpass US$ 1.9 Bn by 2031 Amid Rising Prevalence & Advancements in Treatment - TMR Study here

News-ID: 3931738 • Views:

More Releases from Transparency Market Research

Dengue Testing Market to Reach USD 939.8 Mn by 2035, Expanding at a CAGR of 4.6% - By Product & Service / By Technology / By Sample Type | Asia Pacific • North America • Europe
Dengue Testing Market to Reach USD 939.8 Mn by 2035, Expanding at a CAGR of 4.6% …
The global Dengue Testing Market was valued at US$ 573.1 Mn in 2024 and is projected to reach US$ 939.8 Mn by 2035, expanding at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2035. This steady growth trajectory reflects the rising global burden of dengue fever, increasing diagnostic awareness, and continuous advancements in testing technologies. Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=65456 Dengue has
Global Cell Cryopreservation Market to Reach USD 104.8 Billion by 2035, Driven by Rapid Growth in Cell-Based Therapies
Global Cell Cryopreservation Market to Reach USD 104.8 Billion by 2035, Driven b …
The global Cell Cryopreservation Market is poised for extraordinary growth over the next decade, fueled by accelerating advancements in regenerative medicine, cell-based therapies, and biopharmaceutical research. According to the latest industry outlook, the market was valued at US$ 14.9 billion in 2024 and is projected to reach US$ 104.8 billion by 2035, expanding at a strong compound annual growth rate (CAGR) of 19.4% from 2025 to 2035. Cell cryopreservation has become
Global Private 5G Network Market Outlook 2035: Revenue Expected to Cross US$ 78.2 Billion at 35.2% CAGR
Global Private 5G Network Market Outlook 2035: Revenue Expected to Cross US$ 78. …
The global private 5G network market was valued at US$ 2.8 billion in 2024 and is projected to expand dramatically to US$ 78.2 billion by 2035, registering an exceptional compound annual growth rate (CAGR) of 35.2% during 2025-2035. This exponential growth trajectory reflects the accelerating shift of enterprises toward dedicated, high-performance wireless networks that offer greater control, ultra-low latency, and enhanced security compared to public networks. The scale of this growth
Automotive Rain Sensors Market Outlook 2035: Global Industry is Growing from US$ 5.2 Billion to US$ 9.4 Billion by 2035 at a 6.5% CAGR
Automotive Rain Sensors Market Outlook 2035: Global Industry is Growing from US$ …
The global automotive rain sensors market is experiencing steady growth as vehicle manufacturers increasingly integrate advanced driver assistance features to enhance safety, comfort, and driving convenience. Valued at US$ 5.2 billion in 2024, the market is projected to reach US$ 9.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2035. This growth is supported by rising vehicle production, increasing penetration of smart

All 5 Releases


More Releases for Diverticular

Diverticular Disease Market Size, Share & Growth Analysis
The Diverticular Disease Market is expanding rapidly as cases of diverticulosis and diverticulitis increase worldwide. With aging populations, lifestyle shifts, improved diagnostics, and new treatment options, the market is positioned for strong growth through 2034. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51993 Understanding the Diverticular Disease Market Diverticular disease refers to conditions involving small pouches (diverticula) that form in the colon wall. These include: • Diverticulosis: Presence of pouches, often without symptoms • Diverticulitis:
Future Scope of Diverticular Treatment Market Set for Dynamic Development with K …
Coherent Market Insights has released a report titled "Diverticular Treatment Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins. ➤ Get Sample Copy
Global Diverticular Treatment Market Set for Significant Growth as Awareness and …
The global diverticular treatment market is poised for steady expansion over the next decade, fueled by rising incidences of diverticular disease, increasing elderly population, technological advancements in diagnostics, and a growing preference for non-invasive treatments. Industry stakeholders are witnessing a shift in treatment protocols, innovation in pharmaceutical formulations, and expanding healthcare access in emerging economies. Get a free sample report: https://datahorizzonresearch.com/request-sample-pdf/diverticular-treatment-market-4125 Understanding Diverticular Disease and the Market Landscape Diverticular disease, encompassing diverticulosis and
Diverticular Treatment Market Size 2021 with Key Players Growth Opportunities an …
Latest released, the research study on Global Diverticular Treatment Market Research Report 2021, report comprises growth rate, size, analysis by type, market segment by Application, market competition by manufacturers, share by region, manufacturing cost analysis, Also, the Diverticular Treatment Market offers market breakdown, competitive situation and trends, key raw materials analysis, dynamics, forecast by type, by application and revenue estimates with covid-19 impact till 2027. Get Free sample copy of the
Diverticular Disease Market Expected to Grow 7.5% CAGR with Sucampo Pharmaceutic …
Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber
Diverticular Disease Market 2023 Top Key Players are Sucampo Pharmaceuticals, In …
Market Research Future has added a report titled “Diverticular Disease Market Research Report - Forecast to 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition